Ken Griffin Ab Cellera Biologics Inc. Transaction History

Citadel Advisors LLC

$550 Billion
Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,889,760 shares of ABCL stock, worth $12.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,889,760

Previous 23,500 12196.85%

Holding current value

$12.3 Million

Previous $52,000 18959.62%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.93 - $3.8 $2.08 Million - $4.09 Million	1,075,286 Added 59.26%	2,889,760 $9.91 Million
Q1 2025 May 15, 2025	BUY	$2.2 - $3.53 $2.68 Million - $4.3 Million	1,217,223 Added 203.8%	1,814,474 $4.05 Million
Q4 2024 Feb 14, 2025	SELL	$2.48 - $3.15 $2.24 Million - $2.84 Million	-902,389 Reduced 60.17%	597,251 $1.75 Million
Q3 2024 Nov 14, 2024	BUY	$2.39 - $3.49 $63,167 - $92,240	26,430 Added 1.79%	1,499,640 $3.88 Million
Q2 2024 Aug 14, 2024	BUY	$2.73 - $4.73 $1.93 Million - $3.35 Million	708,377 Added 92.62%	1,473,210 $4.36 Million
Q1 2024 May 15, 2024	BUY	$4.29 - $5.97 $800,200 - $1.11 Million	186,527 Added 32.25%	764,833 $3.46 Million
Q4 2023 Feb 14, 2024	SELL	$3.91 - $5.93 $670,271 - $1.02 Million	-171,425 Reduced 22.86%	578,306 $3.3 Million
Q3 2023 Nov 14, 2023	SELL	$4.6 - $7.95 $6.64 Million - $11.5 Million	-1,444,039 Reduced 65.82%	749,731 $3.45 Million
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $4.07 Million - $5.46 Million	719,890 Added 48.84%	2,193,770 $14.2 Million
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $64,942 - $99,323	8,884 Added 0.61%	1,473,880 $11.1 Million
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $9.18 Million - $14.1 Million	968,448 Added 195.04%	1,464,996 $14.8 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $3.03 Million - $4.51 Million	329,348 Added 196.98%	496,548 $4.91 Million
Q2 2022 Aug 15, 2022	SELL	$5.72 - $10.65 $11,108 - $20,682	-1,942 Reduced 1.15%	167,200 $1.78 Million
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $1.86 Million - $3.52 Million	-248,948 Reduced 59.54%	169,142 $1.65 Million
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $746,548 - $1.02 Million	57,471 Added 15.94%	418,090 $5.98 Million
Q3 2021 Nov 15, 2021	SELL	$14.85 - $21.34 $638,401 - $917,406	-42,990 Reduced 10.65%	360,619 $7.23 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $5.31 Million - $8.99 Million	263,034 Added 187.11%	403,609 $8.88 Million
Q1 2021 May 17, 2021	SELL	$23.29 - $53.2 $6.8 Million - $15.5 Million	-291,782 Reduced 67.49%	140,575 $4.77 Million
Q4 2020 Feb 16, 2021	BUY	$39.0 - $58.9 $16.9 Million - $25.5 Million	432,357 New	432,357 $17.4 Million

Others Institutions Holding ABCL

# of Institutions

148

Shares Held

114M

Call Options Held

488K

Put Options Held

476K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.22B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account